Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04799054
Title A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ascendis Pharma Oncology Division A/S
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | AUS

Facility Status City State Zip Country Details
Ascendis Pharma Investigational Site Duarte California 91010 United States Details
Ascendis Investigational Site Los Angeles California 90067 United States Details
Ascendis Investigational Site Orange California 92868 United States Details
Ascendis Pharma Investigational Site San Francisco California 94158 United States Details
Ascendis Investigational Site Tampa Florida 33612 United States Details
Ascendis Pharma Investigational Site Chicago Illinois 60637 United States Details
Ascendis Pharma Investigational Site Iowa City Iowa 52242 United States Details
Ascendis Pharma Investigational Site Louisville Kentucky 40202 United States Details
Ascendis Pharma Investigational Site Canton Ohio 44718 United States Details
Ascendis Pharma Investigational Site Cincinnati Ohio 45219 United States Details
Ascendis Pharma Investigational Site Cleveland Ohio 44106 United States Details
Ascendis Pharma Investigational Site Pittsburgh Pennsylvania 15232 United States Details
Ascendis Pharma Investigational Site Knoxville Tennessee 37920 United States Details
Ascendis Investigational Site Dallas Texas 75235 United States Details
Ascendis Investigational Site Dallas Texas 75390 United States Details
Ascendis Investigational Site Houston Texas 77030 United States Details
Ascendis Pharma Investigational Site Fairfax Virginia 22031 United States Details
Ascendis Pharma Investigational Site Wollongong New South Wales 2500 Australia Details
Ascendis Pharma Investigational Site Frankston Victoria 3199 Australia Details
Ascendis Investigational Site Bedford Park 5042 Australia Details
Ascendis Investigational Site Dalseo-gu 42601 Korea, Republic of Details
Ascendis Investigational Site Seocho-gu 06591 Korea, Republic of Details
Ascendis Investigational Site Seogu 49201 Korea, Republic of Details
Ascendis Investigational Site Seogu 49267 Korea, Republic of Details
Ascendis Investigational Site Seongnam 13620 Korea, Republic of Details
Ascendis Investigational Site Seoul 03722 Korea, Republic of Details
Ascendis Investigational Site Seoul 05505 Korea, Republic of Details
Ascendis Investigational Site Seoul 06273 Korea, Republic of Details
Ascendis Investigational Site Suwon-si 16247 Korea, Republic of Details
Ascendis Investigational Site Suwon-si 16499 Korea, Republic of Details
Ascendis Investigational Site Amsterdam 1066 Netherlands Details
Ascendis Investigational Site Rotterdam 3015 GD Netherlands Details
Ascendis Investigational Site Barcelona 08003 Spain Details
Ascendis Investigational Site Barcelona 08028 Spain Details
Ascendis Investigational Site Barcelona 08035 Spain Details
Ascendis Investigational Site Barcelona 08908 Spain Details
Ascendis Investigational Site Madrid 28027 Spain Details
Ascendis Investigational Site Madrid 28040 Spain Details
Ascendis Investigational Site Madrid 28041 Spain Details
Ascendis Investigational Site Madrid 28050 Spain Details
Ascendis Investigational Site Murcia 30120 Spain Details
Ascendis Investigational Site Málaga 29010 Spain Details
Ascendis Investigational Site Pamplona 31008 Spain Details
Ascendis Investigational Site Sevilla 41009 Spain Details
Ascendis Investigational Site Valencia 46009 Spain Details
Ascendis Investigational Site Taichung 404 Taiwan Details
Ascendis Investigational Site Taichung 40705 Taiwan Details
Ascendis Investigational Site Tainan 704 Taiwan Details
Ascendis Investigational Site Taipei City 112 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field